semaglutide pk Sem-P™ Injection/Vial (Semaglutide) – Care Connect Pharmacokinetic and pharmacodynamic studies of

This type of administration does not cause irritation, pain, or tenderness, which are common side effects of injections

In the STEP-1 extension trial (N=1,961), participants who stopped semaglutide 2.4 mg at week 68 regained, on average, two-thirds of their lost weight by week 120, while continuing the drug preserved the full 14.9% loss [1]

The complementary mechanisms address injuries from multiple angles simultaneously

Improved Skin Health : Peptides such as collagen peptides promote collagen production, which helps improve skin elasticity, reduce wrinkles, and enhance overall skin health

Lancet 349:17151720 Ricchelli F, Sileikyte J, Bernardi P (2011) Shedding light on the mitochondrial permeability transition